QUEENSBURY, N.Y., December 31, 2025--(BUSINESS WIRE)--Delcath Systems, Inc. (Nasdaq: DCTH), ("Delcath" or the "Company") an interventional oncology company focused on the treatment of primary and ...

Sony has officially announced that slimmer versions of the PlayStation 5 and PlayStation 5 Digital Edition will be arriving just in time for the holidays, and we're here to see not only how they ...

An ad hoc committee will assess the human requirements for energy intake and expenditure. The review will consider age, sex, body size, body composition, level of physical activity, and race/ethnicity ...

Delcath Systems announced that subgroup analyses from its phase 3 FOCUS study of the FDA-approved HEPZATO KIT for unresectable metastatic uveal melanoma were published in the Journal of Cancer ...

Correspondence to Professor Wayne Derman, Institute of Sport and Exercise Medicine, Division of Orthopaedic Surgery, Department of Surgical Sciences, Stellenbosch University Faculty of Medicine and ...

What's Health Got to Do with It? is a weekly talk program that examines where healthcare intersects with daily life, and will help guide the listeners through an increasingly convoluted medical ...

QUEENSBURY, N.Y.--(BUSINESS WIRE)--Delcath Systems, Inc. (Nasdaq: DCTH), (“Delcath” or the “Company”) an interventional oncology company focused on the treatment of primary and metastatic liver ...

Delcath Systems, Inc., an interventional oncology company focused on the treatment of primary and metastatic liver cancers, announced the publication of results from subgroup analyses of the phase 3 ...